Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02240173

Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia

Phase 2 Study of the Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia.

Sponsor: Federal Neuro-Psychiatric Hospital, Yaba

Conditions Schizophrenia and Disorders With Psychotic Features

Updated 7 times since 2017 Last updated: Feb 14, 2017 Started: Jun 30, 2017 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Schizophrenia and Disorders With Psychotic Features, this trial is ongoing. The trial is conducted by Federal Neuro-Psychiatric Hospital, Yaba and has accumulated 7 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Mar 2019 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Mar 2019 [monthly]

Not Yet Recruiting PHASE1_PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

Status: Unknown Status → Not Yet Recruiting
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal Neuro-Psychiatric Hospital, Yaba

Data source: Federal Neuro-Psychiatric Hospital, Yaba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lagos, Nigeria